NOVOSCREEN
LIVE

Serial Number

98265444

Owner

2Pi-Sigma Corp.

Attorney

Ali Makoui

Filing Date

Nov 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NOVOSCREEN Trademark

Serial Number: 98265444

NOVOSCREEN is a trademark filed by 2Pi-Sigma Corp. on November 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

2Pi-Sigma Corp. (2 trademarks)

4343 Von Karman Ave., Suite 250
Newport Beach, CA 92660

Entity Type: 03

Trademark Details

Filing Date

November 10, 2023

Registration Date

Not Registered

Published for Opposition

July 30, 2024

Goods & Services

Antibody testing for medical diagnostic or treatment purposes; Cancer screening services; DNA screening for medical purposes; Health screening services in the field of Alzheimer's disease and all types of cancer; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels; Medical analysis services for the diagnosis of cancer; Medical diagnosis of Alzheimer's disease and all types of cancer; Medical diagnosis and treatment of Alzheimer's disease and all types of cancer; Medical diagnostic testing, monitoring and reporting services; Medical screening; Medical screening services in the field of Alzheimer's disease and all types of cancer; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of Alzheimer's disease and all types of cancer; Virus testing for medical diagnostic or treatment purposes; Providing cancer screening services

Apparatus for blood analysis; Blood testing apparatus; Diagnostic apparatus for the detection of cancer; Immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical device for detecting cancer; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing cancer biomarker levels, Alzheimer's disease; Medical diagnostic instruments for the analysis of body fluids; Medical specimen collection devices in the nature of tubes, microtubes, capillary tubes, vials, micro vials for the collection of blood, urine, saliva

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, all types of cancer, Alzheimer's disease; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, tetrahydrocannabinol (THC); Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test media in the form of strips and microfluidics devices for measuring levels of cancer biomarkers; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2026 EXRA
SOU EXTENSION 3 GRANTED
Mar 4, 2026 EX3G
SOU EXTENSION 3 FILED
Mar 3, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 3, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 3, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 12, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 12, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 11, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 18, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2024 NWOS
NEW APPLICATION ENTERED
Nov 10, 2023 NWAP